(Total Views: 532)
Posted On: 06/03/2019 10:00:42 AM
Post# of 88
$SLS News Article - SELLAS Announces Immune Response Data in Triple Negative Breast Cancer Patients from Phase 2b Study of Nelipepimut-S (NPS) Plus Trastuzumab Presented at ASCO 2019 https://marketwirenews.com/news-releases/sell...89380.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
